InChI=1S/C45H73BNO15/c1-24(2)36(47)39(50)54-27(5)30-16-12-11-13-17-32(48)42(7,8)34-21-19-26(4)45(57-34)38-41(52)56-31-23-29(53-28(31)6)15-14-18-33(49)43(9,10)35-22-20-25(3)44(58-35)37(40(51)55-30)59-46(60-38,61-44)62-45/h11-12,24-38,48-49H,13-23,47H2,1-10H3/q-1/p+1/b12-11-/t25-,26-,27-,28-,29-,30+,31+,32+,33-,34+,35+,36-,37+,38+,44+,45+,46?/m1/s1 |
OOBFYEMEQCZLJL-IIWQOWOFSA-O |
CC(C)[C@@H]([NH3+])C(=O)O[C@H](C)[C@@H]1C\C=C/CC[C@H](O)C(C)(C)[C@@H]2CC[C@@H](C)[C@@]3(O[B-]45O[C@H]3C(=O)O[C@H]3C[C@@H](CCC[C@@H](O)C(C)(C)[C@@H]6CC[C@@H](C)[C@@](O4)(O6)[C@@H](O5)C(=O)O1)O[C@@H]3C)O2 |
|
antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
anti-HIV agent
An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via macrolide antibiotic )
|
|
View more via ChEBI Ontology
[(2R)-1-{(1R)-1-[(1R,2R,5S,6R,8R,12R,14S,17R,18R,19R,22S,24Z,28S,30S,33R)-12,28-dihydroxy-1,2,18,19-tetra(hydroxy-κO)-6,13,13,17,29,29,33-heptamethyl-3,20-dioxo-4,7,21,34,35-pentaoxatetracyclo[28.3.1.15,8.114,18]hexatriacont-24-en-22-yl]ethoxy}-3-methyl-1-oxobutan-2-aminiumato(4−)]boron
|
15307145
|
Reaxys Registry Number
|
Reaxys
|
34524-20-4
|
CAS Registry Number
|
ChemIDplus
|
4651427
|
Reaxys Registry Number
|
Reaxys
|
4651428
|
Reaxys Registry Number
|
Reaxys
|
11952157
|
PubMed citation
|
Europe PMC
|
15638327
|
PubMed citation
|
Europe PMC
|
17991498
|
PubMed citation
|
Europe PMC
|
19055422
|
PubMed citation
|
Europe PMC
|
22475183
|
PubMed citation
|
Europe PMC
|
4066498
|
PubMed citation
|
Europe PMC
|
4247775
|
PubMed citation
|
Europe PMC
|
4465333
|
PubMed citation
|
Europe PMC
|
5131791
|
PubMed citation
|
Europe PMC
|
6081908
|
PubMed citation
|
Europe PMC
|
8695905
|
PubMed citation
|
Europe PMC
|
|